Clinical Trial Update: Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether glutamine can prevent vincristine-induced peripheral neuropathy in children and adolescents with cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Peripheral Neuropathy
• Vincristine-induced Peripheral Neuropathy

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: Ain Shams University | Conditions: Neuropathy, Cancer | Phase 3 | Status: NOT_YET_RECRUITING